CytoSorbents REFRESH 2-AKI Protocol Amendment Approved by FDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Cytosorbents Corporation (NASDAQ: CTSO) | Delayed: 4.85 +0.38 (8.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.47 | 52 Week High | $7.48 | |||
| Open | $4.49 | 52 Week Low | $3.11 | |||
| Day High | $4.85 | P/E | N/A | |||
| Day Low | $4.20 | EPS | $-0.03 | |||
| Volume | 41,324 | |||||
